Katrina Pedersen: Not many people realize that there is NO prospective interventional trial data for FOLFIRI or for a powered Taxane cohort in Small Bowel Adenocarcinoma

Katrina Pedersen, Gastrointestinal Oncologist at Siteman Cancer Center, shared a post by SWOG Cancer Research Network on X/Twitter, adding:

”Not many people realize that there is NO prospective interventional trial data for FOLFIRI or for a powered Taxane cohort in Small Bowel Adenocarcinoma. I know—hard to believe!  Thanks SWOG Cancer Research Network and Michael Overman for dedicating resources to S1922 to fill this critical gap.”

Quoting SWOG Cancer Research Network’s post:

”Small Bowel Adenocarcinoma is often treated with therapies used for gastric or colorectal cancer. Study S1922 tests 2 treatments to learn whether they work specifically against small bowel adenocarcinoma. Learn more here or call 1-800-4-CANCER. Ask about S1922.”

Source: Katrina Pedersen/Twitter and SWOG Cancer Research Network/Twitter